Characteristics of the included studies. حسب Si He (3236646)

الموضوعات:

Trial sequential analysis of primary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Trial sequential analysis of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Pooled effect of the therapeutic effects of negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Forest plots of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Extracted data and used for analysis. حسب Si He (3236646)

الموضوعات:

Excluded studies with reasons for exclusion. حسب Si He (3236646)

الموضوعات:

Flow diagram of the studies included in the meta-analysis. حسب Si He (3236646)

الموضوعات:

Flowchart of the screening process. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the AMSTAR-2 assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Characteristics of included reviews. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the PRISMA assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the ROBIS assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

pRPS6 and proliferation rates of starved Vasa2+/Piwi1+ cells were independent on the daytime of refeeding, and phospho-RPS6 was found in S- and M-phase Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... حسب Sanne Ettema (18786312)

Feeding and starvation affect the proportion and cell cycle activity of Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

The effect of feeding and starvation on the proliferative competence and onset of cell cycle re-entry in all cell cycle-gated cells. حسب Eudald Pascual-Carreras (12115380)

The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

"…<i>n</i> = 2–4 biological replicates per condition, with 15 individuals per replicate. Significance levels for Student <i>t</i> test are indicated for adjusted <i>p</i> values: *<i>p</i> < 0.05, ***<i>p</i> < 0.001, ***<i>p</i> < 0.0001. d: day(s), n.s.: non-significant. …"

Dynamics and functional role of TOR signaling during cell cycle re-entry in Vasa2+/Piwi1+ cells after refeeding. حسب Eudald Pascual-Carreras (12115380)

The effect of feeding and starvation on the proliferative competence and cell cycle re-entry dynamics of Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)